(Q35554448)

English

A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate

scientific article published on 13 April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate (English)

1 reference

Europe PubMed Central

8 August 2017

0 references

multicenter clinical trial

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S B Cohen

1

1 reference

Europe PubMed Central

8 August 2017

L W Moreland

2

1 reference

Europe PubMed Central

8 August 2017

J J Cush

3

1 reference

Europe PubMed Central

8 August 2017

M W Greenwald

4

1 reference

Europe PubMed Central

8 August 2017

S Block

5

1 reference

Europe PubMed Central

8 August 2017

W J Shergy

6

1 reference

Europe PubMed Central

8 August 2017

P S Hanrahan

7

1 reference

Europe PubMed Central

8 August 2017

M M Kraishi

8

1 reference

Europe PubMed Central

8 August 2017

A Patel

9

1 reference

Europe PubMed Central

8 August 2017

G Sun

10

1 reference

Europe PubMed Central

8 August 2017

M B Bear

11

1 reference

Europe PubMed Central

8 August 2017

990145 Study Group

12

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

13 April 2004

1 reference

Europe PubMed Central

8 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

8 August 2017

63

1 reference

Europe PubMed Central

8 August 2017

9

1 reference

Europe PubMed Central

8 August 2017

1062-1068

1 reference

Europe PubMed Central

8 August 2017

Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

27 July 2018

Rise in serum C reactive protein after hip and knee arthroplasties in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

27 July 2018

Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

27 July 2018

Interleukin-1 receptor antagonist: role in biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

27 July 2018

Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

27 July 2018

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

27 July 2018

Cytokine concentrations in the synovial fluid and plasma of rheumatoid arthritis patients: correlation with bony erosions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

27 July 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

27 July 2018

Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

27 July 2018

Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

27 July 2018

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

26 September 2018

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755108

26 September 2018

Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimum important difference between patients with rheumatoid arthritis: the patient's perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/15082469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2003.016014

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35554448&oldid=1579022449"